These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 11674863

  • 1. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF, Newby LJ, Heptinstall S.
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y12 and P2Y1 antagonists but not aspirin.
    Storey RF, May JA, Heptinstall S.
    Thromb Res; 2005 Nov; 115(4):301-7. PubMed ID: 15668190
    [Abstract] [Full Text] [Related]

  • 3. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S.
    Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease.
    Storey RF, Wilcox RG, Heptinstall S.
    Platelets; 2002 Nov; 13(7):407-13. PubMed ID: 12487788
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

  • 6. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM, Koo YK, Jin J, Lee YY, Park S, Yun-Choi HS.
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [Abstract] [Full Text] [Related]

  • 7. The P2Y12 receptor as a therapeutic target in cardiovascular disease.
    Storey RF.
    Platelets; 2001 Jun; 12(4):197-209. PubMed ID: 11454254
    [Abstract] [Full Text] [Related]

  • 8. Differential involvement of the P2Y1 and P2YT receptors in the morphological changes of platelet aggregation.
    Eckly A, Gendrault JL, Hechler B, Cazenave JP, Gachet C.
    Thromb Haemost; 2001 Apr; 85(4):694-701. PubMed ID: 11341507
    [Abstract] [Full Text] [Related]

  • 9. Adenosine diphosphate receptors on blood platelets: potential new targets for antiplatelet therapy.
    Rozalski M, Nocun M, Watala C.
    Acta Biochim Pol; 2005 Apr; 52(2):411-5. PubMed ID: 15912207
    [Abstract] [Full Text] [Related]

  • 10. DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic disease.
    Heptinstall S, Espinosa DI, Manolopoulos P, Glenn JR, White AE, Johnson A, Dovlatova N, Fox SC, May JA, Hermann D, Magnusson O, Stefansson K, Hartman D, Gurney M.
    Platelets; 2008 Dec; 19(8):605-13. PubMed ID: 19012178
    [Abstract] [Full Text] [Related]

  • 11. Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes.
    Behan MW, Fox SC, Heptinstall S, Storey RF.
    Platelets; 2005 Mar; 16(2):73-80. PubMed ID: 15823862
    [Abstract] [Full Text] [Related]

  • 12. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S, Schwarz T, Craddock-Royal B, Tagliente TM.
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [Abstract] [Full Text] [Related]

  • 13. Mode of action of P2Y(12 ) antagonists as inhibitors of platelet function.
    Iyú D, Glenn JR, White AE, Fox SC, van Giezen H, Nylander S, Heptinstall S.
    Thromb Haemost; 2011 Jan; 105(1):96-106. PubMed ID: 20941457
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore.
    Joseph S, Krishnamurthi S, Kakkar VV.
    Thromb Haemost; 1987 Apr 07; 57(2):191-5. PubMed ID: 3110996
    [Abstract] [Full Text] [Related]

  • 16. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood.
    Heptinstall S, May JA, Glenn JR, Sanderson HM, Dickinson JP, Wilcox RG.
    Thromb Haemost; 1995 Nov 07; 74(5):1310-5. PubMed ID: 8607115
    [Abstract] [Full Text] [Related]

  • 17. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K, Lange D, Presek P.
    Thromb Haemost; 2004 Jul 07; 92(1):114-23. PubMed ID: 15213852
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.